Aaron Miller

6.5k citations

119 papers · 4.0k indexed · 1 hit paper · h-index 31

Impact in

Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies
Neurology top 1%
- Peripheral Neuropathies and Disorders

Papers in

Pathology and Forensic Medicine 84
- Multiple Sclerosis Research Studies 80
Rheumatology 32
- Rheumatoid Arthritis Research and Therapies 14
- Systemic Lupus Erythematosus Research 11

Co-authors: Jerry S. Wolinsky Paul O’Connor Ludwig Kappos Tomas Olsson Mark Freedman Philippe Truffinet Gıancarlo Comı Christian Confavreux
Journals: Neurology (23 papers)Multiple Sclerosis Journal (23 papers)Multiple Sclerosis and Related Disorders (10 papers)Journal of Clinical Investigation (3 papers)American Journal of Hematology (3 papers)
Partner nations: United States Canada Italy

In The Last Decade

Aaron Miller

115 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial 2014 · 402 citations

Peers

Countries citing papers authored by Aaron Miller

Since Specialization

Citations

This map shows the geographic impact of Aaron Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Miller more than expected).

Fields of papers citing papers by Aaron Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Miller. The network helps show where Aaron Miller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aaron Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aaron Miller Line = papers co-authored together Aaron Miller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cognition in multiple sclerosis within the modern diagnostic and treatment era Brain ·James Sumowski, Sarah Levy, Ilana Katz Sand, Rachel Brandstadter, Emily Dvorak, XIONG Changxin, Michelle Fabian, 佳奈上村, Fred Lublin, Aaron Miller, Joshua Sandry	2025	0
2	Operative Epidemiology of the First Five Years in a New African Neurosurgery Training Center: The Experience in Rural Kenya at Tenwek Hospital 2016 to 2021 World Neurosurgery ·Е.В. Пономаренко, Aaron Miller, Zilola SALISHEVA, Ryouich Komori, 민족민주운동연구소, 凯朱, Hugh Sims-Williams, Fraser Henderson, González González Madrigal	2024	1
3	Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells Journal for ImmunoTherapy of Cancer ·Gregory P. Botta, Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia, 貴浩川上, Joy Nolte Fong, St. Šalkauskis, Lakeisha Johnson, Aaron Miller, Michael Y. Choi, Benjamin Heyman, Gregory A. Daniels, Dan S. Kaufman, Catriona Jamieson, Zonghai Li, Ezra E.W. Cohen	2024	15
4	Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies Multiple Sclerosis Journal ·Till Sprenger, Ludwig Kappos, Maria Pia Sormani, Aaron Miller, Elizabeth M. Poole, R. S. Roman, Jens Wuerfel	2022	8
5	A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment Multiple Sclerosis Journal ·Jeffrey A. Cohen, Michelle Cameron, Myla Goldman, Andrew Goodman, Aaron Miller, 譚達先, Lily Llorens, Rajiv Patni, Robert Elfont, Reed Johnson	2021	3
6	Detection of subtle gait disturbance and future fall risk in early multiple sclerosis Neurology ·Rachel Brandstadter, Muinat Nike Lewu, Stephen Krieger, Noam Y. Harel, Miguel X. Escalón, Ilana Katz Sand, Victoria M. Leavitt, Michelle Fabian, Korhan Buyukturkoglu, Sylvia Klineova, Claire Riley, Fred Lublin, Aaron Miller, James Sumowski	2020	35
7	Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019) Multiple Sclerosis Journal ·Jan D. Lünemann, Marina Reiter Braun, Bruno Stankoff, Carolyn Young, Aksel Sıva, Aaron Miller, Catherine Lubetzki, Heinz Wiendl, Celia Oreja‐Guevara	2020	0
8	Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis JAMA Neurology ·Aaron Miller, Tanuja Chitnis, Bruce A. Cohen, Kathleen Costello, Nancy L. Sicotte, 채문기	2020	43
9	Outcomes of the TOPIC Extension Study of Teriflunomide in Patients With Early Multiple Sclerosis: Up to 7 Years of Clinical Results (P2.103) Neurology ·Aaron Miller, Mark Freedman, Jiwon Oh, J. de Sèze, Philippe Truffinet, Myriam Bénamor, Annie Purvis, Gıancarlo Comı	2017	2
10	Efficacy of Teriflunomide in Early-Stage MS: Reanalysis of the TOPIC Study Using 2010 McDonald Diagnostic Criteria (P7.274) Neurology ·Flavia Nelson, François Evoy, Thomas Berger, Philippe Truffinet, Déborah Bauer, Aaron Miller, Jerry S. Wolinsky	2015	2
11	Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis Clinical Therapeutics ·Aaron Miller	2015	34
12	Rationale for EDSS-Plus, the Primary Composite Endpoint of Disability Progression in the ASCEND Phase 3 Study of Natalizumab for Secondary Progressive Multiple Sclerosis: A Post Hoc Analysis of IMPACT Study Data (P7.240) Neurology ·Daniel D. Mikol, J. A. Cohen, Mark Freedman, Myla Goldman, Hans‐Peter Hartung, Eva Havrdová, Douglas Jeffery, Raj Kapoor, Aaron Miller, Finn Sellebjerg, Karmen Čorak, Sophia Lee, Diego Cadavid	2015	1
13	Teriflunomide for the treatment of relapsing–remitting multiple sclerosis Expert Review of Clinical Immunology ·Aaron Miller	2014	4
14	Teriflunomide Treatment Is Not Associated With Increased Risk of Infections: Pooled Data From the Teriflunomide Development Program (P2.194) Neurology ·B. Singer, Cristoforo Comi, Aaron Miller, Mark Freedman, Myriam Bénamor, Philippe Truffinet	2014	1
15	Patients Free of Clinical MS Activity in TEMSO and TOWER: Pooled Analyses of Two Phase 3 Placebo-Controlled Trials (P3.164) Neurology ·Tomas Olsson, Gıancarlo Comı, Mark Freedman, Aaron Miller, Jerry S. Wolinsky, Philippe Truffinet, R. S. Roman, Deborah Dukovic, Paul O’Connor, Ludwig Kappos	2014	1
16	Pre-Defined Subgroups Analyses of TOWER, a Placebo-Controlled Phase 3 Trial of Teriflunomide in Patients with Relapsing Multiple Sclerosis (S41.006) Neurology ·Harold Moses, Mark Freedman, Ludwig Kappos, Aaron Miller, Tomas Olsson, Jerry S. Wolinsky, Christian Confavreux, Gıancarlo Comı, Teresa Bagulho, Yan Zheng, Philippe Truffinet, Paul O’Connor	2013	4
17	All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States Journal of Managed Care Pharmacy ·Carl V. Asche, Mendel E. Singer, Mehul Jhaveri, Mengchu Lin, Aaron Miller	2010	90
18	Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial Annals of Neurology ·Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor, Patricia K. Coyle, Corey C. Ford, Kenneth P. Johnson, Aaron Miller, Yun Hou, Shaul Kadosh, David Ladkani, (unknown)	2007	297
19	Assessing the Withdrawal of Natalizumab Journal watch ·Aaron Miller	2005	1
20	Sialic Acid Content of the Erythrocyte and of an Ascites Tumor Cell of the Mouse Cancer Research ·Aaron Miller, John Sullivan, Jay H. Katz	1963	27

About Aaron Miller

Aaron Miller is a scholar working on Pathology and Forensic Medicine, Rheumatology, Neurology, Hematology and Developmental Neuroscience, having authored 119 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (80 papers), Peripheral Neuropathies and Disorders (22 papers), Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (11 papers), Polyomavirus and related diseases (9 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers) and Fungal Plant Pathogen Control (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.9k citations), Neurology (1.2k citations), Rheumatology (952 citations), Developmental Neuroscience (141 citations) and Hematology (343 citations). Aaron Miller has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jerry S. Wolinsky, Paul O’Connor, Ludwig Kappos, Tomas Olsson, Mark Freedman, Philippe Truffinet, Gıancarlo Comı, Christian Confavreux, Stephen Krieger and Ilana Katz Sand. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Journal of Clinical Investigation and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact